HEALTHALLAFRICA
Congo-Kinshasa: New Ebola Vaccine Trial Launches As Outbreak Spreads in DR Congo
A new Ebola vaccine trial for the Bundibugyo species is underway in the Democratic Republic of the Congo as the outbreak spreads, with rising cases and deaths. The World Health Organization noted efforts to develop the world's first vaccine for this strain, though results may take months.
Mentioned
Related Signal
Adjacent reporting
- Congo-Kinshasa: Ebola Outbreak Worsens
- Congo-Kinshasa: Oxford Begins Ebola Vaccine Trial
- Ebola treatment trial begins in DRC, WHO says
- Congo-Kinshasa: Epidemic Coalition Focuses on Bundibugyo Ebola Vaccine
- WHO launches clinical trial for new Ebola treatment in DR Congo
- WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola